Special Issue "Head and Neck Cancer"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (31 August 2015)
This year, nearly 70,000 new cases of Head and Neck Cancer will be diagnosed. The major causes of head and neck cancer-related deaths are persistent or recurrent disease. Despite focused research, the five-year survival rate for patients with advanced head and neck cancer remains approximately 15-20 percent. Head and Neck cancers are debilitating diseases where patient prognosis depends heavily on complete tumor resection. Recent advances in both the laboratory and the clinic continue to improve the outcome for patients. This Special Issue of Cancers gives an opportunity to describe recent original research in the field of Head & Neck Cancer, the development or application of new platforms or insights, and/or reviews of the field. We are particularly interested in genomics, immunomodulators, novel therapeutics, tumor margin localization, and new biomarker studies. (If you would like to discuss an idea for a paper before committing please contact the Guest Editor or the Editorial Office.)
Dr. Maie A. St. John
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cancer imaging
- early cancer detection
- intraoperative cancer imaging
- imaging of tumor margins
- novel therapeutic platforms
- immune checkpoints